Skip to main content

Table 2 Fracture events of patients who completed the 18-months study duration

From: Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates

Study period of TPTD administration −18 ~ −13 months −12 ~ −7 months −6 ~ 0 months 0 ~ 6 months 7 ~ 12 months 13 ~ 18 months
Patients 0 1 6 0 0 1
Fracture events 0 1 7 0 0 1
  1. This table shows the number of total fracture events and patients with new fractures before or after TPTD administration